Please login to the form below
New NHS library to support involving public in healthcare
The Patient and Public Involvement (PPI) Specialist Library, which is a collection of current knowledge and evidence about patient and public involvement in healthcare has been added to the existing NHS National Library for Health.
The Patient and Public Involvement (PPI) Specialist Library, which is a collection of current knowledge and evidence about patient and public involvement in healthcare has been added to the existing NHS National Library for Health.
The new library, which is run by the King's Fund for the National Library for Health, is targeted at NHS managers, researchers and students and provides the latest information on user involvement in policy development and self-care, as well as strengthening NHS accountability to patients and local communities.
The PPI Specialist Library will support the implementation of patient, user, carer and public involvement in health care by providing access, in one location, to the best information available.
Ray Phillips, head of Information Service Development at the King's Fund, said: ìWe are pleased to support the National Library for Health by developing and managing this new Specialist Library. We are sure that managers, carers, and service users will find this an invaluable resource, and that it will assist them in implementing and developing patient and public involvement in their area.î
The PPI Specialist Library can be found at www.library.nhs.uk/ppi
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
-
CEO, Head of Health, UK
-
Six figure salary
-
Omnichannel Strategy Consultant
-
Competitive Salary
-
CEO Pricing & Market Access, UK
-
Six figure salary
-
Senior Account Manager
-
Competitive salary offered
- Valneva COVID-19 vaccine more effective than AZ
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes
- bluebird bio provides update on 2seventy bio spin-off
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Live Webinar: Using Cybersecurity to Maintain Patient Data Integrity
- Merck’s COVID-19 antiviral under review in Europe by EMA
- AZ’s Imfinzi boosts survival in biliary tract cancer
- MAKING THE FIRST YEAR MATTER
- Merck receives first breast cancer approval in Europe for Keytruda
- Benefits of COVID-19 vaccine in younger children outweigh risks, says FDA
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes
- The FDA vaccine advisory board recommends booster shots of both the J&J and Moderna vaccines
- Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
- Curb your conservatism: can pharma ditch its cautious approach to creativity in comms?
PMHub
foxandcat.online
some pressure is helpful but too much of the wrong sort quickly takes its toll. we help creatove agenices manage...
Latest intelligence
- The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
- The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
- Mind the Gap – Challenging Immunisation Apathy and Misinformation
- world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
- Towards Better HCP Engagement – An Email Masterclass
- 6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....
